Top Markets
Coin of the day
Vaxil Bio Ltd. Vaxil Bio Ltd.

Vaxil Bio Ltd.

VXL
株式のランク #39496
Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing... Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.
株価
$0.1174299
最終同期: 2026-08-13
時価総額
$467.84K
変化(1日)
-8.57%
変化(1年)
1.38%
CA
取引 Vaxil Bio Ltd. (VXL)

カテゴリー

Vaxil Bio Ltd.(VXL)の株価履歴
終値の最高値: $0.13 (2026-08-01)

終値の最安値: $137.64 (2010-03-01)
Vaxil Bio Ltd. の株価履歴(2010 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 24.66%
2025 -72.61%
2024 -24.06%
2023 -28.26%
2022 -76.68%
2021 -41.79%
2020 258.87%
2019 16.10%
2018 -52.29%
2017 -41.76%
2016 16.83%
2015 -19.78%
2014 -67.07%
2013 -46.95%
2012 -44.33%
2011 -48.81%
2010 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$734.04 7.47%
CH
$1.07K -6.40%
KR
$257.75 13.87%
BE